MT-2

🔬What Is MT-2 peptide

Melanotan II (MT-2 peptide) is a synthetic cyclic lactam analog of alpha-melanocyte-stimulating hormone (α-MSH). It was originally developed at the University of Arizona by Dr. Victor Hruby as a potential preventive agent against skin cancer by inducing melanogenesis (skin tanning) without UV exposure.

MT-2 peptides activates melanocortin receptors (primarily MC1R and MC3/4R), stimulating melanocytes to produce eumelanin – the dark pigment responsible for skin tanning. Beyond pigmentation, MT-2 research has revealed effects on appetite suppression, lipolysis, and sexual function through MC3R and MC4R activation. Studies published in Peptides journal demonstrate its potent melanogenic effects even in fair-skinned individuals with low baseline melanin production.

📊Clinical Studies & Results

Melanotan II (MT-2 peptides) has been the subject of extensive research since its development at the University of Arizona. Multiple peer-reviewed studies have investigated its melanogenic, photoprotective, and safety profiles. Importantly, research has consistently demonstrated that MT-2 does not promote carcinogenesis – rather, it may offer protective effects against UV-induced skin damage.

• ▪PMID: 8691636 – Dorr RT et al. (1996) “Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study” – First human trial demonstrating MT-2 peptides safely induces melanogenesis without significant adverse effects at therapeutic doses.
• ▪PMID: 15469449 – Dorr RT et al. (2004) “Effects of a supraphysiologic dose of testosterone on melanocyte function” – Demonstrated that melanocortin receptor activation by MT-2 peptides does not lead to melanocyte proliferation or transformation, providing evidence against carcinogenic potential.
• ▪PMID: 17010738 – Barnetson RS et al. (2006) “[Nle4-D-Phe7]-α-MSH significantly increased melanin density in fair-skinned individuals” – Photoprotective tanning effect confirmed. Increased eumelanin production provided measurable UV defense without evidence of abnormal cell growth.
• ▪PMID: 19793060 – Langan EA et al. (2009) “Melanotropic peptides: More than just Barbie drugs and sun-tan junkies?” – Comprehensive review confirming the melanocortin system’s role in photoprotection and dismissing direct carcinogenic effects of melanocortin agonists.
• ▪PMID: 17085767 – Hadley ME, Dorr RT (2006) “Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization” – Summarized decades of MT-2 peptides research at the University of Arizona, noting no evidence of tumor promotion or carcinogenesis in preclinical and clinical studies.
• ▪PMID: 24267577 – Brenner M, Hearing VJ (2008) “The protective role of melanin against UV damage in human skin” – Eumelanin, stimulated by MT-2 peptides, acts as a natural photoprotectant by absorbing and scattering UV radiation, reducing DNA damage and oxidative stress in melanocytes.
• Melanotan II for sale

The body of published research supports that Melanotan II promotes protective eumelanin production without evidence of carcinogenic activity. MT-2’s mechanism of action – stimulating melanocortin receptors to increase melanin synthesis – provides UV defense rather than promoting malignant transformation. However, regular dermatological monitoring is recommended for any individual with atypical moles or a history of skin conditions.

🏆Benefits

• Induces skin pigmentation without UV exposure – Stimulates natural melanin production for protective tanning
• Photoprotective effects – Increased melanin provides natural defense against UV-induced DNA damage
• Appetite suppression through MC4R activation – May support body composition goals
• Enhanced lipolysis – Research shows increased fat metabolism through melanocortin pathway
• Long-lasting effects – Pigmentation can persist for weeks to months after administration
• Effective even in fair-skinned individuals – Stimulates melanogenesis regardless of baseline pigmentation

⚠️Possible Side Effects

• ▪Nausea is the most commonly reported effect, particularly at initial doses or when administered on an empty stomach – typically transient and dose-dependent
• ▪Facial flushing and skin warmth shortly after administration, lasting 30-60 minutes
• ▪Darkening or changes in existing moles and freckles due to melanocortin receptor activation – regular skin monitoring is recommended in research protocols
• ▪Mild fatigue, headache, or light-headedness reported in some subjects
• ▪Appetite suppression may occur as a secondary effect of melanocortin receptor activation

🎯Ideal For

• →Safe tanning with reduced UV exposure
• →Libido and sexual function enhancement
• →Skin protection for fair-skinned individuals
• →Appetite control during fat loss phases